NCT06050421 (RODBT-AN) is a NA clinical trial of Radically Open Dialectical Behaviour Therapy (RO-DBT) in Anorexia Nervosa, sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau.

Who is sponsoring NCT06050421?

NCT06050421 is sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau.

What condition does NCT06050421 study?

NCT06050421 studies Anorexia Nervosa, Anorexia Nervosa in Remission, Anorexia Nervosa Restricting Type.

Is NCT06050421 still recruiting?

NCT06050421 is currently recruiting now. Last updated 22 September 2023.

Last reviewed 2023-09-22 · How we verify

NCT06050421: RODBT-AN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Radically Open Dialectical Behaviour Therapy in Patients With Anorexia Nervosa

Recruiting now NA Last updated 22 September 2023

What this trial tests

NA trial testing Radically Open Dialectical Behaviour Therapy (RO-DBT) in Anorexia Nervosa in 96 participants. Currently enrolling.

Timeline

22 June 2023

Primary endpoint
31 December 2025

30 June 2026

Quick facts

Lead sponsor	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	single
Primary purpose	treatment
Enrollment	96
Start date	22 June 2023
Primary completion	31 December 2025
Estimated completion	30 June 2026
Sites	1 location across Spain

Drugs / interventions tested

Radically Open Dialectical Behaviour Therapy (RO-DBT)
Treatment As Usual
No intervention

Conditions studied

Anorexia Nervosa — all drugs for Anorexia Nervosa →
Anorexia Nervosa in Remission — all drugs for Anorexia Nervosa in Remission →
Anorexia Nervosa Restricting Type — all drugs for Anorexia Nervosa Restricting Type →

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Who can join

Adults 18 to 65, female only, with Anorexia Nervosa or Anorexia Nervosa in Remission. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized controlled clinical trial to evaluate the efficacy of "Radically Open Dialectical Behaviour Therapy" in patients with eating disorders: a proof-of-concept study.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Evaluating the efficacy of radically open dialectical behavior therapy (RO-DBT) in patients with anorexia nervosa: study protocol for a randomized controlled clinical trial.
Avila-Parcet A, Martín-Blanco A, Gawron L, Cano M, et al · · 2025 · cited 1× · PMID 40251556 · DOI 10.1186/s12888-025-06854-9
Evaluating the efficacy of Radically Open Dialectical Behavior Therapy (RO-DBT) in patients with anorexia nervosa: study protocol for a randomized controlled clinical trial
Avila-Parcet A, Martín-Blanco A, Gawron L, Cano M, et al · · 2024 · DOI 10.21203/rs.3.rs-4414466/v1

Verify or expand the search:

Other trials of Radically Open Dialectical Behaviour Therapy (RO-DBT)

Trials testing the same drug.

NCT06244576 — Emotional Dysregulation, Maladaptive Overcontrol in Anorexia - Effect of Radically Open Dialectical Behaviour Therapy · NA · unknown

Other recruiting trials for Anorexia Nervosa

Currently open trials in the same condition.

NCT07169747 — Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young · Phase 2 · recruiting
NCT07237607 — Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders · NA · recruiting
NCT07188155 — Adapting Exposure for Adolescent AN · NA · recruiting
NCT07143981 — The Fecal Microbiome Transplant (FMT) Study for Anorexia Nervosa · recruiting
NCT07311356 — Prognosis of Early-onset Anorexia Nervosa · recruiting

Other Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau trials

Trials by the same sponsor.

NCT07343882 — Quantification of Systemic Congestion by Ultrasound As a Predictor of Weaning Failure From Mechanical Ventilation · NA · not yet recruiting
NCT07530237 — Efficacy of Periarticular Vasoconstrictor Infiltration (PVI) in Reducing Bleeding and Postoperative Pain in Lumbar Fusio · active not recruiting
NCT07369310 — Comparing Biomarker-Guided DBS Programming With Standard Clinical Monopolar Programming · NA · not yet recruiting
NCT07314190 — Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodege · enrolling by invitation
NCT07239843 — Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychia · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06050421 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Last refreshed: 22 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06050421.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing